Literature DB >> 3281217

Lessons learned from animal models of osteomyelitis.

C W Norden1.   

Abstract

Because of the marked variability in presentation and management of osteomyelitis in patients, research with animal models that mimic the human disease offers a more controlled approach. Presently available animal models have been used to study pathogenesis, diagnosis, and treatment of osteomyelitis. Each model has advantages and disadvantages. Although it seems improbable that an ideal model of osteomyelitis will be achieved in the near future, further efforts to develop new experimental models and innovative research with present models are clearly needed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281217     DOI: 10.1093/clinids/10.1.103

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  30 in total

Review 1.  Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?

Authors:  J Ciampolini; K G Harding
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

Review 2.  Animal models as predictors of the safety and efficacy of antibiotics.

Authors:  O Zak; T O'Reilly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

3.  Bone and joint infections.

Authors:  T Louie
Journal:  Can J Infect Dis       Date:  1992-03

4.  Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity.

Authors:  Dan Li; Kirill Gromov; Kjeld Søballe; J Edward Puzas; Regis J O'Keefe; Hani Awad; Hicham Drissi; Edward M Schwarz
Journal:  J Orthop Res       Date:  2008-01       Impact factor: 3.494

5.  Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.

Authors:  Christopher Faber; Hein P Stallmann; D M Lyaruu; Uwe Joosten; Christof von Eiff; Arie van Nieuw Amerongen; Paul I J M Wuisman
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 6.  Fungal arthritis.

Authors:  M L Cuéllar; L H Silveira; L R Espinoza
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

Review 7.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

8.  Animal models in the evaluation of antimicrobial agents.

Authors:  O Zak; T O'Reilly
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

9.  Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.

Authors:  P Dellamonica; E Bernard; H Etesse; R Garraffo; H B Drugeon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

10.  Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses.

Authors:  A Saleh Mghir; A C Crémieux; R Bleton; F Ismael; M Manteau; S Dautrey; L Massias; L Garry; N Sales; B Mazière; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.